Position in OGN
as of Mar 31, 2026
· filed May 14, 2026
Position Value
$314,211
-$53,601 QoQ
Shares Held
52,456
+112.4% QoQ
Ownership
0.020%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2022
7 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in OGN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Jump Financial, LLC holds $60,679,237 across 7 Drug Manufacturers - General names.
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
30,924 | $37,091,175 | |
| 2 | GILD |
Gilead Sciences, Inc.
|
88,471 | $11,177,425 | |
| 3 | NVO |
Novo Nordisk A S
|
123,187 | $5,905,584 | |
| 4 | JNJ |
Johnson & Johnson
|
14,450 | $3,669,866 | |
| 5 | ABBV |
AbbVie Inc.
|
9,600 | $2,415,743 | |
| 6 | PFE |
Pfizer Inc
|
9,470 | $228,037 | |
| 7 | AMRN |
Amarin Corp Plc\Uk
|
12,008 | $191,407 |
All Filings in OGN
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $314,211 | 52,456 | Shares | Defined | 2026-05-14 | |
| 2025-03-31 | $367,812 | 24,702 | Shares | Defined | 2025-05-14 | |
| 2024-12-31 | $213,356 | 14,300 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $656,865 | 34,337 | Shares | Defined | 2024-11-14 | |
| 2022-12-31 | $406,241 | 14,545 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $449,349 | 19,203 | Shares | Sole | 2022-11-07 | |
| 2022-06-30 | $455,692 | 13,502 | Shares | Sole | 2022-08-09 | |
| No filing history on record for this holder in this stock. | ||||||